Longeveron Inc.

US$1.81As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LGVNHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (65.70%)
Div yield —
ROE (203.61%)
Biotechnology
Beta (5Y) 0.91
PE TTM —
TSR TTM (78.29%)
Mkt cap US$5.771M
ROIC (118.32%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.73
(4.25%)
(94.00%)
Hold 1|1|2|6|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.04
0.04
24.90%
19.38%
18.58%
20.19%
Revenue$M
0.334
0.327
0.320
0.334
2.51%
2.24%
(3.88%)
2.78%
Peers (US$5.771M)
Cap (US$)
PE
6.217M
—
Capital
TTM
5Y
10Y
Leveragex
0.054
0.403
0.390
EBIT/Intx
2.609
0.369
0.365
Own earn%
112.18
(2.86)
1.58
Sh yield%
26.98
35.15
30.49
Owners
Insiders/Inst%
2.68
33.52
Short interest%
5.95
SBC / revenue%
4.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
5–13
$1 testx
—
Incr. ROIC%
1